...
首页> 外文期刊>Journal of Pain Research >Differential drug effects on spontaneous and evoked pain behavior in a model of trigeminal neuropathic pain
【24h】

Differential drug effects on spontaneous and evoked pain behavior in a model of trigeminal neuropathic pain

机译:在三叉神经痛模型中,差异药物对自发性和诱发性疼痛行为的影响

获取原文

摘要

Purpose: Baclofen and morphine have shown efficacy against mechanical allodynia after infraorbital nerve chronic constriction injury (IoN-CCI). No drug effects have yet been reported on spontaneous trigeminal neuropathic pain. It has been proposed that the directed face grooming behavior that also develops following IoN-CCI offers a measure of spontaneous trigeminal neuropathic pain. Subjects and methods: We examined the effects of a continuous 1-week infusion of 30 mg/day?carbamazepine (the first-line drug treatment for trigeminal neuralgia), 1.06 mg/day baclofen, 4.18 mg/day clomipramine, and 5 mg/day morphine on spontaneous and mechanically evoked pain behavior (ie, directed face grooming and von Frey testing) in IoN-CCI rats. Results: Isolated face grooming was significantly reduced in rats receiving carbamazepine and baclofen but not in clomipramine- or morphine-treated rats. All drugs showed significant antiallodynic effects; carbamazepine showed the strongest effects, whereas clomipramine had only minor efficacy. Conclusion: The tested drugs have differential effects in the IoN-CCI model, and different neuropathological mechanisms may underlie the different somatosensory symptoms in this model. A mechanism-based approach may be needed to treat (trigeminal) neuropathic pain. The present data support IoN-CCI as a model of trigeminal neuralgia in which isolated face grooming is used as a measure of spontaneous neuropathic pain.
机译:目的:巴氯芬和吗啡已显示出对眶下神经慢性压迫性损伤(IoN-CCI)后机械性异常性疼痛的功效。尚无关于自发性三叉神经痛的药物报道。已经提出,在IoN-CCI之后也发展的定向面部修饰行为提供了自发性三叉神经痛的量度。对象和方法:我们研究了连续1周输注30 mg /天卡马西平(三叉神经痛的一线药物治疗),1.06 mg /天巴氯芬,4.18 mg /天氯米帕明和5 mg /吗啡对IoN-CCI大鼠自发性和机械性诱发的疼痛行为(即定向面部修饰和von Frey测试)的影响。结果:接受卡马西平和巴氯芬的大鼠中孤立的脸部修饰明显减少,而经氯米帕明或吗啡治疗的大鼠则没有。所有药物均显示出明显的抗痛觉过敏作用;卡马西平显示出最强的作用,而氯米帕明仅有次要的作用。结论:受试药物在IoN-CCI模型中具有不同的作用,并且不同的神经病理机制可能是该模型中不同的体感症状的基础。可能需要基于机制的方法来治疗(三叉神经性)神经性疼痛。本数据支持IoN-CCI作为三叉神经痛模型,其中孤立的面部修饰被用作自发性神经性疼痛的量度。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号